Carboplatin Paclitaxel - ClinicalTrials.gov

A Phase 2, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial Comparing Chemoimmunotherapy (Paclitaxel-Carboplatin-Oregovomab) Versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) as Neoadjuvant Therapy in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma

Patients with newly diagnosed advanced ovarian cancer who are scheduled to receive neoadjuvant therapy are expected to receive neoadjuvant therapy in a schedule dependent sequence with specific cycles of a common six-cycle chemotherapy regimen.

Source link: https://clinicaltrials.gov/ct2/show/NCT05605535

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions